Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

HCV Protease

NS2-3 protease (of hepatitis C virus, HCV) is an enzyme responsible for proteolytic cleavage between NS2 and NS3, which are non-structural proteins that form part of the HCV virus particle. NS3 protease of hepatitis C virus, on the other hand, is responsible for the cleavage of non-structural protein downstream. Both of these proteases are directly involved in HCV genome replication, that is, during the viral life-cycle that leads to virus multiplication in the host that has been infected by the virus.

Glecaprevir
T51261365970-03-1
Glecaprevir (ABT-493) is an HCV NS3 4A protease inhibitor, (IC50s: 3.5-11.3 nM).
  • $32
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Setrobuvir
T287621071517-39-9In house
Setrobuvir (ANA-598) is an orally active non-nucleoside HCV NS5B polymerase inhibitor with inhibitory effects on de novo RNA synthesis and primer extension with IC50s between 4 and 5 nM. setrobuvir shows good binding affinity for SARS-CoV-2 RdRp and induces inhibition of RdRp.
  • $240
In Stock
Size
QTY
TargetMol | Inhibitor Hot
JTK-109
T27696480462-62-2In house
JTK-109 is an inhibitor of hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor and inhibits G1b and G3a subgenomic replicons and recombinant enzymes.
  • $329
In Stock
Size
QTY
R-1479
TQ0162478182-28-4
R-1479 (4'-Azidocytidine) is an RdRp inhibitor with an IC50 value of 1.28 μM for HCV RNA replication in the HCV subgenomic replicon system.
  • $137
In Stock
Size
QTY
TTP-8307
T13221950225-08-8In house
TTP-8307 is an antiviral compound that inhibits the replication of rhinoviruses and enteroviruses, and inhibits coxsackievirus B3 and poliovirus by interfering with viral RNA synthesis.TTP-8307 can be used in the study of viral infections.
  • $954
In Stock
Size
QTY
Uprifosbuvir
T290691496551-77-9In house
Uprifosbuvir (MK-3682) is a uridine nucleoside monophosphate prodrug inhibitor of hepatitis C virus NS5B RNA polymerase with antiviral activity for the study of chronic hepatitis C virus.
  • $84 TargetMol
In Stock
Size
QTY
Azvudine
T144891011529-10-4
Azvudine (FNC) is a potent nucleoside reverse transcriptase inhibitor (NRTI), with antiviral activity on HIV, HBV and HCV. Azvudine inhibits NRTI-resistant viral strains. Azvudine exerts highly potent inhibition on HIV-1 (EC50s ranging from 0.03 to 6.92 nM) and HIV-2 (EC50s ranging from 0.018 to 0.025 nM).
  • $57
In Stock
Size
QTY
Asunaprevir
T4474630420-16-5
Asunaprevir (BMS-650032) is an effective hepatitis C virus (HCV) NS3 protease inhibitor.
  • $44
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Resiquimod
T6964144875-48-9
Resiquimod (R848) is a Toll-like receptor 7 8 (TLR7 TLR8) agonist that induces cytokine upregulation. Resiquimod is an immunomodulator with antitumor and antiviral activity.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
BILB-1941
T26815494856-61-0In house
BILB-1941 (BILB-1941ZW) is an inhibitor of HCV NS5B polymerase and can be used in studies about HCV infection.
  • $329
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Elbasvir
T45441370468-36-2
Elbasvir (MK-8742) is an inhibitor of nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) being developed as a component of treatment regimens for chronic HCV infection.
  • $37
In Stock
Size
QTY
Beclabuvir
T10493958002-33-0
Beclabuvir is an allosteric inhibitor that binds to thumb site 1 of the HCV NS5B RNA-dependent RNA polymerase, inhibiting recombinant NS5B proteins from HCV genotypes 1, 3, 4, and 5 (IC50 < 28 nM).
  • $137
In Stock
Size
QTY
Danoprevir
T6025850876-88-9
Danoprevir (RG7227) is a peptidomimetic inhibitor of the NS3 4A protease(IC50=0.2-3.5 nM) of hepatitis C virus (HCV).
  • $57
In Stock
Size
QTY
Clemizole
T1822442-52-4
Clemizole, an H1 histamine receptor antagonist, inhibits NS4B's RNA binding and hepatitis C virus (HCV) replication.
  • $37
In Stock
Size
QTY
Simeprevir
T4686923604-59-5
Simeprevir (TMC435) is a potent HCV NS3 4A protease inhibitor, and inhibits HCV replication with EC50 of 8 nM.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Chlorcyclizine
T971782-93-9
CHLORCYCLIZINE is a histamine H1 antagonist and a potent hepatitis C virus (HCV) entry inhibitor.
  • $30
In Stock
Size
QTY
Voxilaprevir
T198621535212-07-7
Voxilaprevir is an inhibitor of hepatitis C virus (HCV) nonstructural (NS) protein 3 4A protease.
  • $89
In Stock
Size
QTY
Myriocin
T1616535891-70-4
Myriocin (Thermozymocidin), a metabolite derived from Myriococcum albomyces, is a serine-palmitoyltransferase (SPT) inhibitor with potential antitumour, anticancer, and antiparasitic activities.Myriocin inhibits tumour growth by regulating macrophage polarisation and function through the PI3K Akt mTOR pathway.Myriocin inhibits HCV infection and can be used in the study of neurological diseases. Myriocin inhibits HCV infection and can be used to study neuropathy and fungal infections.
  • $199
In Stock
Size
QTY
U18666A
T171903039-71-2
U18666A is a cell-permeable drug and is a cholesterol synthesis and transport inhibitor. It inhibits replication of Ebola virus, dengue virus, and human hepatitis C virus.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
Ribavirin
T068436791-04-5
Ribavirin (Tribavirin) is a synthetic nucleoside analog of ribofuranose with activity against hepatitis C virus and other RNA viruses.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
Grazoprevir
T45471350514-68-9
Grazoprevir (MK-5172) is a nitrogenous macrocyclic compound used as an inhibitor of the hepatitis C virus NS3 4A protease. Grazoprevir is commonly combined with elbasvir for treating chronic HCV genotype 1 or 4 infections in adults.
  • $41
In Stock
Size
QTY
Daclatasvir
T62291009119-64-5
Daclatasvir (EBP 883) (BMS-790052) is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. Phase 3.
  • $35
In Stock
Size
QTY
TargetMol | Citations Cited
Paritaprevir
T223941216941-48-8
Paritaprevir (ABT450) is an inhibitor of non-structural protein 3 4A protease with EC50 values of 1 and 0.21 nM for HCV 1a and HCV 1b, respectively.
  • $43
In Stock
Size
QTY
TargetMol | Inhibitor Sale
MK-0608
T16088443642-29-3
MK-0608 is an orally bioavailable HCV replication inhibitor in vitro(EC50 = 0.3 μM and EC90=1.3 μM in the subgenomic-replicon assay).
  • $74
In Stock
Size
QTY
Deferiprone
T156530652-11-0
Deferiprone (Deferidone) is an Iron Chelator. The mechanism of action of deferiprone is as an Iron Chelating Activity.
  • $42
In Stock
Size
QTY
TargetMol | Citations Cited
SB-734117
T9580607368-97-8
SB-734117 inhibits productive replication of several HCMV strains. SB-734117 exhibited polypharmacology and was an inhibitor of several proteins from the AGC and CMCG kinase groups.
  • $117
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Saikosaponin B2
T381058316-41-9
Saikosaponin B2 acts on HCV E2 and inhibits infection by several genotypic strains and prevents binding of serum-derived HCV onto hepatoma cells. Saikosaponin B2 (5 μM) induces differentiation of B16 melanoma cells, with potentiation of expressions of tyr
  • $36
In Stock
Size
QTY
BDCRB
T67887 In house
BDCRB inhibits herpesvirus DNA maturation. BDCRB causes the HCMV terminase to skip the normal cleavage site and to continue to package DNA until a second cleavage site is encountered 30 kb further along the concatemer.
  • $133
In Stock
Size
QTY
Gentiopicroside
T277020831-76-9
Gentiopicroside (Gentiopicrin), a naturally occurring iridoid glycoside, extracted from Gentiana manshurica Kitag, inhibits P450 activity, with an IC50 and a Ki of 61 μM and 22.8 μM for CYP2A6; has antianti-inflammatoryand antioxidative effects.
  • $38
In Stock
Size
QTY
TargetMol | Citations Cited
Letermovir
T5396917389-32-3
Letermovir (AIC246) (AIC246) is a novel anti-CMV compound (EC50: about 5 nM in fibroblast cells). It targets the pUL56 subunit of the viral terminase complex.
  • $80
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Peretinoin
TQ006481485-25-8
Peretinoin (NIK333) is an oral acyclic retinoid with a vitamin A-like structure that targets retinoid nuclear receptors such as RXR and RAR.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Sale
BLT-1
T14667321673-30-7
BLT-1 is a scavenger receptor BI (SR-BI)inhibitor.
  • $38
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Mericitabine
T16710940908-79-2
Mericitabine (R-7128) is a nucleoside HCV NS5B polymerase inhibitor. It acts as an RNA chain terminator and prevents the elongation of RNA transcripts during replication.
  • $45
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Filibuvir
T15282877130-28-4In house
Filibuvir (PF-00868554) is a selective and noncovalent inhibitor of HCV NS5B RNA-dependent RNA polymerase. Filibuvir inhibits genotype 1a and 1b replicons with EC50s of 59 nM.
  • $38
In Stock
Size
QTY
Ledipasvir
T62001256388-51-8
Ledipasvir (GS-5885) is a Hepatitis C Virus NS5A Inhibitor. The mechanism of action of ledipasvir is as a P-Glycoprotein Inhibitor, and Breast Cancer Resistance Protein Inhibitor.
  • $32
In Stock
Size
QTY
Maribavir
T2162176161-24-3
Maribavir (GW257406X) is an orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV). Maribavir is a selective ATP competitor of the viral UL97 kinase, which is involved in viral nuclear maturation events, such as viral DNA assembly and movement of viral capsids from the nucleus of infected cells. Maribavir has activity against strains of CMV that are resistant to standard anti-CMV agents.
  • $36
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Mulberroside C
T5S1598102841-43-0
1. Mulberroside C has antioxidant activity.
  • $81
In Stock
Size
QTY
IDX184
T275861036915-08-8In house
IDX184 is a potent, orally active, targeted HCV polymerase inhibitor and nucleoside polymerase.IDX184 effectively inhibits HCV polymerase (IC50=0.31 μM, Ki=52.3 nM). IDX184 is a liver-targeted nucleotide prodrug with anti-HCV activity that inhibits HCV NS5B polymerase and can be used in combination with pegylated interferon-α2a and ribavirin for the primary treatment of chronic hepatitis C. It has been shown to inhibit HCV polymerase and nucleoside polymerase.
  • $191
In Stock
Size
QTY
RO8191
T22142691868-88-9
RO8191 (CDM-3008) (CDM-3008) is an agonist of interferon (IFN) receptor.
  • $38
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
Ombitasvir
T71581258226-87-7
Ombitasvir (ABT-267) is an orally bioavailable and potent inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A).with EC50s of 0.82 to 19.3 pM against HCV genotypes 1 to 5, and 366 pM against genotype 6a
  • $36
In Stock
Size
QTY
Dasabuvir
T34891132935-63-7
Dasabuvir (ABT-333) is a non-nucleoside inhibitor of the hepatitis C virus (HCV) non-structural protein 5B (NS5B), an RNA-dependent RNA polymerase. Upon administration and intracellular uptake, dasabuvir binds HCV NS5B polymerase, blocking viral RNA synthesis and replication. The HCV NS5B protein is essential for the replication of the HCV RNA genome.
  • $33
In Stock
Size
QTY
TargetMol | Citations Cited
Ruzasvir
T680151613081-64-3In house
Ruzasvir (MK-8408) is a novel and potent pan-genotypic inhibitor of hepatitis C virus NS5A with antiviral activity.
  • $191
In Stock
Size
QTY
Bemnifosbuvir hemisulfate
T93312241337-84-6
Bemnifosbuvir hemisulfate (AT-527) is a potent inhibitor of HCV virus replication.
  • $53
In Stock
Size
QTY
TargetMol | Inhibitor Sale
FGI-106 tetrahydrochloride
T11281L1149348-10-6
FGI-106 tetrahydrochloride demonstrates potent inhibitory activity across a broad spectrum of viruses, including those causing hemorrhagic fevers such as Ebola, Rift Valley, and Dengue Fever, with half-maximal effective concentrations (EC50s) of 100 nM, 800 nM, and 400-900 nM, respectively. Additionally, it effectively inhibits non-hemorrhagic fever viruses, notably HCV and HIV-1, with EC50s of 200 nM and 150 nM, respectively, indicating its broad-spectrum antiviral potential.
  • $79
In Stock
Size
QTY
Mizoribine
T118850924-49-7
Mizoribine (NSC-289637) belongs to the family of 1-Ribosyl-imidazolecarboxamides. Mizoribine has been investigated for the treatment of Rheumatoid Arthritis.
  • $45
In Stock
Size
QTY
Merimepodib
T3444198821-22-6
Merimepodib (VX-497) is a novel, noncompetitive inhibitor of inosine monophosphate dehydrogenase (IMPDH).
  • $39
In Stock
Size
QTY
TargetMol | Inhibitor Sale
AG-1478
T2047153436-53-4
AG-1478 (NSC-693255) (Tyrphostin AG-1478) is a selective EGFR inhibitor.
  • $45
In Stock
Size
QTY
TargetMol | Citations Cited
ITX5061
T156031252679-52-9
ITX5061 is a type II inhibitor of p38 MAPK and an antagonist of scavenger receptor B1 (SRB1), used for studying hepatitis C virus infection.
  • $215
In Stock
Size
QTY